Rare diseases
Investigational molecules
Locations
Astondo Bidea 612, 48160, Spain
Mikrobiomik Healthcare Company S.L. focuses on clinical research in gastroenterology, with activity centred on recurrent diverticulitis and related intestinal inflammation. Its trials reflect interest in conditions involving the colon, digestive tract, and microbiota-based therapies.
The sponsor’s work in this area is directed toward treatment options for patients with repeated episodes of diverticular disease and associated gastrointestinal burden.
Mikrobiomik Healthcare Company S.L. runs clinical trials in conditions such as Metabolic dysfunction-associated steatohepatitis, Non-alcoholic steatohepatitis, Diverticulitis, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Study on MBK-01 and Drug Combination for Treating Patients with Recurrent Diverticulitis
SpainStudy of Fecal Microbiota Capsules for Treating Non-Alcoholic Steatohepatitis in Patients
SpainStudy on Fecal Microbiota Capsules vs. Placebo for Treating Non-Alcoholic Steatohepatitis in Patients
SpainIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
